Instruction for use: Actrapid HM

ATX Code A10AB Short-acting insulins and their analogs for injection

Active substance Insulin soluble [human biosynthetic]

Pharmacological group

Hypoglycemic agent - short-acting insulin [Insulins]

Composition and form of release

Solution for injection 1 ml

Insulin soluble [human genetically engineered] 100 IU (3.5 mg)

1 MU corresponds to 0.035 mg of anhydrous human insulin

Auxiliary substances: zinc chloride; Glycerin (glycerol); Meta-cresol; Sodium hydroxide and / or hydrochloric acid (for pH adjustment); water for injections

10 ml in glass bottles, sealed with rubber stopper and plastic cap; In a pack of cardboard 1 bottle.

pharmachologic effect

Pharmacological action - hypoglycemic.

Dosing and Administration

P / to, in / in. The dose of the drug is selected individually according to the needs of the patient. Usually the patient needs insulin from 0.3 to 1 IU / kg / day. The daily requirement for insulin can be higher in patients with insulin resistance (for example, during puberty, as well as in obese patients) and lower in patients with residual endogenous insulin production. If patients with diabetes mellitus achieve optimal control of glycemia, then complications of diabetes in them, as a rule, manifested later. In this regard, we should strive to optimize metabolic control, in particular, by carefully monitoring the level of glucose in the blood.

Actrapid® HM is a short-acting insulin and can be used in combination with long-acting insulins.

The drug is administered 30 minutes before a meal or a light snack containing carbohydrates. Actrapid® HM is usually injected into the anterior abdominal wall. If this is convenient, then injections can also be made to the thigh area, gluteal region or the deltoid muscle region of the shoulder. When the drug is injected into the anterior abdominal wall, a faster absorption is achieved than when injected into other areas. Doing an injection in the skin fold reduces the risk of getting into the muscle.

It is necessary to change the injection site within the anatomical area to prevent the development of lipodystrophy.

In / m injections are also possible, but only for the doctor's prescription.

Actrapid® NM can also be administered iv, and such procedures can only be performed by a medical professional.

Correction of the dose

If the kidneys or liver is affected, the need for insulin decreases.

Storage conditions

In the refrigerator, at a temperature of 2-8 ° C (do not freeze). The opened vial should be stored at room temperature not higher than 25 ° C for 6 weeks; Do not store in the refrigerator. The drug should be protected from heat and sunlight.

Keep out of the reach of children.

Shelf life

2.5 years.

Do not use after the expiry date printed on the package.